Postscript 65 and PSPC September Bulletins

1 view
Skip to first unread message

Galbraith, Susan

unread,
Sep 20, 2011, 12:15:51 PM9/20/11
to nhsggc-p...@googlegroups.com

The latest 'Postscript' and 'Postscript Primary Care' bulletins are now available on the Formulary Website.

 

PSPC - September 2011 [Available at: http://www.glasgowformulary.scot.nhs.uk/prescriber/PSPC%20-%201109.pdf]

 

- Dabigatran

- Respiratory Prescribing Indicators

- Apidra supply problem

- CD Instalment Prescriptions

- Sip Feeds

 

Postscript 65 [Available at: http://www.ggcformulary.scot.nhs.uk/Postscript/PostScript%2065.pdf]

 

·         Focus on opiate substitution therapy: strategies to reduce the harm from prescribing methadone

·         An introduction to individual patient treatment requests

·         Smoking cessation and effects on drug metabolism

·         SIGN guideline app

·         Latest ADTC decisions

·         Webwatch: Stockley's Drug Interactions and the Drug and Therapeutics Bulletin

 

Comments and suggestions for future editions always welcome.

 

Regards

Susan

 

Susan Galbraith

Prescribing Adviser

Prescribing Team

Queens Park House

Victoria Infirmary

Langside Road

Glasgow, G42 9TT

susan.ga...@ggc.scot.nhs.uk

susan.g...@nhs.net

 

****************************************************************************
NHSGG&C Disclaimer

The information contained within this e-mail and in any attachment is
confidential and may be privileged. If you are not the intended
recipient, please destroy this message, delete any copies held on your
systems and notify the sender immediately; you should not retain, copy
or use this e-mail for any purpose, nor disclose all or any part of its
content to any other person.

All messages passing through this gateway are checked for viruses, but
we strongly recommend that you check for viruses using your own virus
scanner as NHS Greater Glasgow & Clyde will not take responsibility for
any damage caused as a result of virus infection.

**************************************************************************

Reply all
Reply to author
Forward
0 new messages